trustme.bro/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim
Cancer cells emit specific volatile organic compounds as chemical signatures
the verdict
SUPPORTED
the evidence backs this
refutedsupported
the weight of evidence
7 sources for · 0 against

Multiple clinical and in vitro studies demonstrate that cancer cells and tumors emit specific volatile organic compounds that serve as detectable chemical signatures for non-invasive diagnostics.

Evidence for · 7
Emerging Electronic Nose Design for Breath-Based Cancer Diagnostics: Advances in Machine Learning Approaches and Sensor Architecture Design.
2026 · cited by 2
Reviews electronic nose technologies for detecting cancer-related volatile organic compounds in breath.
See more details
The analysis

The claim states that cancer cells emit specific volatile organic compounds as chemical signatures. Papers [0], [1], [2], [3], [4], [5], and [8] all provide strong empirical or review evidence that cancer cells, tissues, and tumors produce distinct volatile organic compounds that can be detected in vitro or via breath analysis to identify various cancers. There are no refuting papers.

More for · 6
Direct sampling of the peripheral lung identifies lung-derived volatile organic compounds detectable in exhaled breath: a feasibility study.
2026 · cited by 0
Demonstrates that volatile organic compounds originating in the lung microenvironment are detectable in exhaled breath for lung cancer screening.
Metal-organic frameworks for breath-based sensors: a review.
2026 · cited by 0
Discusses breath-based disease diagnosis by analyzing volatile organic compounds as unusual products of metabolism.
A novel approach to non-invasive lung cancer screening via exhaled breath analysis using proton transfer reaction time-of-flight mass spectrometry.
2026 · cited by 0
Identifies specific volatile organic compound ions in exhaled breath that differentiate lung cancer patients from controls.
Discriminating colorectal cancer via exhaled volatile organic compounds.
2026 · cited by 0
Finds a panel of exhaled volatile organic compounds that successfully discriminates colorectal cancer from controls and other conditions.
Volatilomic Signatures of Parental and Oxaliplatin-Resistant HCT116 Colon Cancer Cell Lines.
2026 · cited by 0
Demonstrates that colorectal cancer cell lines emit distinct volatile organic compound profiles reflecting cellular metabolism.
Electronic nose versus gas chromatography - mass spectrometry for diagnostic discrimination of advanced hepatocellular carcinoma by volatolomic analysis.
2026 · cited by 0
Shows that volatile organic compound profiling via eNose and GC-MS successfully distinguishes hepatocellular carcinoma patients from controls.
Everything we examined (12)
  1. Emerging Electronic Nose Design for Breath-Based Cancer Diagnostics: Advances in Machine Learning Approaches and Sensor Architecture Design.peer-reviewedsupports
  2. Direct sampling of the peripheral lung identifies lung-derived volatile organic compounds detectable in exhaled breath: a feasibility study.peer-reviewedsupports
  3. Metal-organic frameworks for breath-based sensors: a review.peer-reviewedsupports
  4. A novel approach to non-invasive lung cancer screening via exhaled breath analysis using proton transfer reaction time-of-flight mass spectrometry.peer-reviewedsupports
  5. Discriminating colorectal cancer via exhaled volatile organic compounds.peer-reviewedsupports
  6. Volatilomic Signatures of Parental and Oxaliplatin-Resistant HCT116 Colon Cancer Cell Lines.peer-reviewedsupports
  7. Sweet Interference: Oral Fermentation Volatile Confounders In Exhaled Breath Revealed by Minimal Glucose Exposurepeer-reviewedno side takennot shown: read and judged not to bear on this claim
  8. Exhaled breath volatiles for asthma diagnosis: discovery and validation in untreated but symptomatic patients.peer-reviewedno side takennot shown: read and judged not to bear on this claim
  9. Electronic nose versus gas chromatography - mass spectrometry for diagnostic discrimination of advanced hepatocellular carcinoma by volatolomic analysis.peer-reviewedsupports
  10. Measurement of immune cell-derived volatile organic compounds from ex vivo and in vitro cultures: a scoping review.peer-reviewedno side takennot shown: read and judged not to bear on this claim
  11. Exploratory Volatilome Profiling of Inflammation in Skin Fibroblasts: A Proof-of-Concept Study.peer-reviewedno side takennot shown: read and judged not to bear on this claim
  12. Breath by Breath: Navigating the Landscape of Exhaled Breath in Clinical Research and Prospects for the Future.peer-reviewedno side takennot shown: read and judged not to bear on this claim
The paper trail · every fact has a biography
first checked05 Aug 2026
judged → SUPPORTED · 7805 Aug 2026
This receipt carries no identity, shared or not. Sharing publishes your connection to it, not your data.
Check your own claim
Challenge the receipt
trust me, bro: win the argument, pass the class, survive peer review.
This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work · Dispute this receipt